CA2660954A1 - Nouveau sel de derive de 1,3,5-triazine-2,4,6-triamine - Google Patents

Nouveau sel de derive de 1,3,5-triazine-2,4,6-triamine Download PDF

Info

Publication number
CA2660954A1
CA2660954A1 CA2660954A CA2660954A CA2660954A1 CA 2660954 A1 CA2660954 A1 CA 2660954A1 CA 2660954 A CA2660954 A CA 2660954A CA 2660954 A CA2660954 A CA 2660954A CA 2660954 A1 CA2660954 A1 CA 2660954A1
Authority
CA
Canada
Prior art keywords
compound
crystal
around
salt
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2660954A
Other languages
English (en)
Inventor
Junya Ohmori
Makoto Kasai
Takenori Kimura
Noritaka Hamada
Ryo Mizoguchi
Satoshi Miyamoto
Noriyuki Kawano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Priority to CA2660954A priority Critical patent/CA2660954A1/fr
Priority to JP2011541013A priority patent/JP2012521964A/ja
Priority to PCT/JP2010/056143 priority patent/WO2010114162A1/fr
Priority to EP10714103A priority patent/EP2414351A1/fr
Priority to TW099109852A priority patent/TW201034673A/zh
Publication of CA2660954A1 publication Critical patent/CA2660954A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA2660954A 2009-03-31 2009-03-31 Nouveau sel de derive de 1,3,5-triazine-2,4,6-triamine Abandoned CA2660954A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA2660954A CA2660954A1 (fr) 2009-03-31 2009-03-31 Nouveau sel de derive de 1,3,5-triazine-2,4,6-triamine
JP2011541013A JP2012521964A (ja) 2009-03-31 2010-03-30 １，３，５−トリアジン−２，４，６−トリアミン誘導体の新規な塩
PCT/JP2010/056143 WO2010114162A1 (fr) 2009-03-31 2010-03-30 Nouveau sel d'un dérivé de 1,3,5-triazine-2,4,6-triamine
EP10714103A EP2414351A1 (fr) 2009-03-31 2010-03-30 Nouveau sel d'un dérivé de 1,3,5-triazine-2,4,6-triamine
TW099109852A TW201034673A (en) 2009-03-31 2010-03-31 Novel salt of 1,3,5-triazine-2,4,6-triamine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2660954A CA2660954A1 (fr) 2009-03-31 2009-03-31 Nouveau sel de derive de 1,3,5-triazine-2,4,6-triamine

Publications (1)

Publication Number Publication Date
CA2660954A1 true CA2660954A1 (fr) 2010-09-30

Family

ID=42174540

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2660954A Abandoned CA2660954A1 (fr) 2009-03-31 2009-03-31 Nouveau sel de derive de 1,3,5-triazine-2,4,6-triamine

Country Status (5)

Country Link
EP (1) EP2414351A1 (fr)
JP (1) JP2012521964A (fr)
CA (1) CA2660954A1 (fr)
TW (1) TW201034673A (fr)
WO (1) WO2010114162A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024075841A1 (fr) * 2022-10-07 2024-04-11 Okinawa Institute Of Science And Technology School Corporation Aptamère d'arn qui se lie à asp7967 ou à un analogue de celui-ci

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1625410A (zh) * 2002-02-05 2005-06-08 山之内制药株式会社 2,4,6－三氨基－1,3,5－三嗪衍生物

Also Published As

Publication number Publication date
JP2012521964A (ja) 2012-09-20
WO2010114162A1 (fr) 2010-10-07
TW201034673A (en) 2010-10-01
EP2414351A1 (fr) 2012-02-08

Similar Documents

Publication Publication Date Title
EP3782998B1 (fr) Composé de pyrrolotriazine substitué, composition pharmaceutique et utilisation associées
EP3222614B1 (fr) Composé de biguanide et utilisation de celui-ci
DK2873664T3 (en) Crystalline form I of tyrosine kinase inhibitor dimethylate and its preparation processes
TWI672305B (zh) 一種ｊａｋ激酶抑制劑的硫酸氫鹽的結晶形式及其製備方法
WO2022221493A1 (fr) Dérivés d'urée de pipéridine utilisés en tant qu'inhibiteurs d'époxyde hydrolase soluble
EP2970128B1 (fr) Sels d'addition de base de nitroxoline et leurs utilisations
EP3193874A1 (fr) Formes cristallines d'inhibiteurs de la tyrosine kinase et leurs sels
WO2021121146A1 (fr) Forme cristalline a d'un composé d'aminopyrimidine mésylate, son procédé de préparation et son utilisation
RU2652992C2 (ru) Новая кристаллическая солевая форма 3-(1,2,4-триазоло[4,3-а]пиридин-3-илэтинил)-4-метил-n-(4-((4-метилпиперазин-1-ил)метил)-3-трифторметилфенил)бензамида для медицинского применения
CA2660954A1 (fr) Nouveau sel de derive de 1,3,5-triazine-2,4,6-triamine
WO2012147832A1 (fr) Cristal dérivé du phénylpyrrole
US8399663B2 (en) Salt of 1,3,5-triazine-2,4,6-triamine derivative
AU2009201337A1 (en) Novel salt of 1, 3, 5-triazine-2, 4, 6-triamine derivative
KR20110095400A (ko) 아자비사이클로－트리플루오로메틸 벤즈아미드 유도체의 신규한 다형태
JPWO2004020433A1 (ja) 新規結晶
US20100256152A1 (en) Novel pharmaceutical composition for treatment of schizophrenia
WO2011145548A1 (fr) Cristaux de composé di(arylamino)arylé
CN113861183B (zh) 取代的嘧啶哌嗪化合物的盐及其用途
BRPI0901279A2 (pt) sal de derivado de 1,3,5-triazino-2,4,6-triamina
CA2660962A1 (fr) Nouvelle composition pharmaceutique pour le traitement de la schizophrenie
WO2024056079A1 (fr) Forme polymorphe de sel d'addition d'acide nepicastat, son procédé de préparation et son utilisation
CA3215383A1 (fr) Composition pharmaceutique, son procede de preparation et son application
EA043251B1 (ru) Кристаллическая форма соединения для ингибирования активности cdk4/6 и ее применение
AU2009201338A1 (en) Novel pharmaceutical composition for treatment of schizophrenia
US20110166348A1 (en) Novel salt of morpholine derivative

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20150331